Leadership
David Zhang, CEO
David previously held the position of Associate Professor of Bioengineering at Rice University, where he was honored with the Presidential Early Career Award for Scientists and Engineers (PECASE) in 2019. He has made significant contributions to scientific literature, co-authoring over 60 peer-reviewed publications, which have amassed more than 9,000 citations, and has been granted 50 patents. In his entrepreneurial endeavors, David's previous startup, Nuprobe Global, successfully raised over $110 million in venture funding and generated revenues exceeding $20 million in 2022.
Ashwin Gopinath, CTO
Ashwin's prior role was Associate Professor of Mechanical Engineering at MIT, where he and his team developed the Reflexion method, a notable advancement aimed at enhancing the reasoning capabilities of large language models (LLM), with their findings published at NeurIPS in 2023. Ashwin has also co-authored more than 45 peer-reviewed publications, including articles in prestigious journals like Nature and Science. His entrepreneurial journey includes founding the startup company Palamedrix, which was acquired by Somalogic for over $50 million in 2022.
Team Leaders:
Eva Miao, Head of Operations
Wei Chen, Assc. Director of Transcriptomics
